Logo

PainReform Ltd.

PRFX

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting… read more

Healthcare

Drug Manufacturers—Specialty & Generic

5 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.70

Price

+8.74%

$0.06

Market Cap

$1.405m

Small

Price/Earnings

0x

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$0.00

-

1y CAGR

-33.3%

3y CAGR

-25.0%

5y CAGR
Earnings

-$4.086m

+72.0%

1y CAGR

+3.2%

3y CAGR

-2.9%

5y CAGR
EPS

-$2.30

+92.9%

1y CAGR

+62.5%

3y CAGR

+44.0%

5y CAGR
Book Value

$8.443m

$11.162m

Assets

$2.719m

Liabilities

$56k

Debt
Debt to Assets

0.5%

-

Debt to EBITDA
Free Cash Flow

-$5.960m

+52.8%

1y CAGR

-13.2%

3y CAGR

-9.4%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases